General Information of the Compound
| Compound ID |
CP0462452
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[4-(3-chloro-4-fluoroanilino)-7-[(1-phenyltriazol-4-yl)methoxy]quinazolin-6-yl]prop-2-enamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H19ClFN7O2
|
||||||||||||||||||
| Molecular Weight |
515.936
|
||||||||||||||||||
| Canonical SMILES |
Fc1ccc(Nc2ncnc3cc(OCc4cn(nn4)-c4ccccc4)c(NC(=O)C=C)cc23)cc1Cl
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H19ClFN7O2/c1-2-25(36)32-23-11-19-22(29-15-30-26(19)31-16-8-9-21(28)20(27)10-16)12-24(23)37-14-17-13-35(34-33-17)18-6-4-3-5-7-18/h2-13,15H,1,14H2,(H,32,36)(H,29,30,31)
Show/Hide
|
||||||||||||||||||
| InChIKey |
GPRREFHLBPUWFY-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Protein ID: PT01233, Receptor tyrosine-protein kinase erbB-2